Literature DB >> 19201167

Synthesis and cell activity of novel galactosylated chitosan as a gene carrier.

Baofeng Song1, Wei Zhang, Rong Peng, Jie Huang, Ting Nie, Ying Li, Qing Jiang, Rong Gao.   

Abstract

It is important for gene carrier to transport DNA into target cells. Although viral vectors are very efficient gene-transfer vehicles, significant drawbacks limit their applications. Chitosan (CS) has been researched widely as a non-viral vector. However, the low cell specificity and low transfection efficiency of chitosan need to be overcome. In order to conquer the drawback of chitosan, the present paper is concerned with the synthesis of novel galactosylated chitosan (GC) through etherization of chitosan and galactose in THF using BF(3).OEt(2) as promoter. The final product was characterized and confirmed by FT-IR and (1)H NMR. The degree of O-substitution (DS) of chitosan by galactose was measured to be 10.38% using anthrone-sulfuric acid colorimetric method. The mean particle diameter and average zeta potential of the GC/DNA complex were 350 nm and +22.1 mV, respectively. The GC/DNA nanoparticle was tested to transfect HEK293 cells, and the viability of HEK293 cells was not affected by the GC/DNA nanoparticle compared to that of the control.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19201167     DOI: 10.1016/j.colsurfb.2008.12.018

Source DB:  PubMed          Journal:  Colloids Surf B Biointerfaces        ISSN: 0927-7765            Impact factor:   5.268


  5 in total

1.  Design and synthesis of dual-ligand modified chitosan as a liver targeting vector.

Authors:  Houxiang Chen; Min Li; Tao Wan; Qichang Zheng; Mingrong Cheng; Shiqi Huang; Yong Wang
Journal:  J Mater Sci Mater Med       Date:  2011-11-22       Impact factor: 3.896

2.  Preparation of Betulinic Acid Galactosylated Chitosan Nanoparticles and Their Effect on Liver Fibrosis.

Authors:  Zi Chao Wu; Xin Yu Liu; Jia Yan Liu; Jing Shu Piao; Ming Guan Piao
Journal:  Int J Nanomedicine       Date:  2022-09-14

3.  Galactosylated chitosan/5-fluorouracil nanoparticles inhibit mouse hepatic cancer growth and its side effects.

Authors:  Ming-Rong Cheng; Qing Li; Tao Wan; Bing He; Jiang Han; Hou-Xiang Chen; Feng-Xiao Yang; Wei Wang; Hong-Zhi Xu; Tao Ye; Bing-Bing Zha
Journal:  World J Gastroenterol       Date:  2012-11-14       Impact factor: 5.742

4.  Physicochemical and Biological Insights Into the Molecular Interactions Between Extracellular DNA and Exopolysaccharides in Myxococcus xanthus Biofilms.

Authors:  Yan Wang; Tingyi Li; Weiwei Xue; Yue Zheng; Yipeng Wang; Ning Zhang; Yue Zhao; Jing Wang; Yuezhong Li; Chuandong Wang; Wei Hu
Journal:  Front Microbiol       Date:  2022-04-22       Impact factor: 5.640

5.  Galactosylated chitosan oligosaccharide nanoparticles for hepatocellular carcinoma cell-targeted delivery of adenosine triphosphate.

Authors:  Xiu Liang Zhu; Yong Zhong Du; Ri Sheng Yu; Ping Liu; Dan Shi; Ying Chen; Ying Wang; Fang Fang Huang
Journal:  Int J Mol Sci       Date:  2013-07-29       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.